Nebula Genomics

Nebula Genomics

Created using Figma
Created using Figma
制药和生物技术公司每年花费数十亿美元来获取基因组数据。科学家需要大型基因组数据集来确定疾病的原因并开发治疗方法。然而,基因组数据市场的增长受到小数据量,数据碎片化,缺乏数据标准化和数据采集速度缓慢的阻碍。 Nebula Genomics将利用区块链技术消除中间人并使人们能够拥有他们的个人基因组数据。这将有效降低测序成本并增强数据隐私,从而导致基因组数据的增长。我们的开放式协议将利用基因组数据增长,使数据购买者能够有效地汇总来自许多个体和基因组数据库的标准化数据。
风险:非常高
6月, 2018
6月, 2018
100% 完成
募集资金 - 无数据
past
令牌详细信息
接受的货币
ETH
公司详情
注册国家
United States
额外细节
KYC
分类
健康, 大数据

关于 Nebula Genomics

The first human genome was sequenced in 2001 at a cost of $3 billion. Today, human genome sequencing costs less than $1000, and in a few years the price will drop below $100. Thus, personal genome sequencing will soon be widely adopted as it enables better diagnosis, disease prevention, and personalized therapies. Furthermore, if genomic data is shared with researchers, the causes of many diseases will be identified and new drugs developed. These opportunities are creating a genomic data market worth billions of dollars.

Nebula Genomics seeks to lead this emerging market by understanding and overcoming key obstacles. We will spur genomic data growth by significantly reducing the costs of personal genome sequencing, enhancing genomic data protection, enabling buyers to efficiently acquire genomic data, and addressing the challenges of genomic big data. We will accomplish this through decentralization, cryptography, and utilization of the blockchain.

SEQUENCING COSTS - The Nebula peer-to-peer network will enable data buyers to acquire genomic data directly from data owners without middlemen. This will enable data owners to receive sequencing subsidies from data buyers and profit from sharing their data. Reducing sequencing costs will accelerate growth of genomic data.

DATA PROTECTION - Data owners will privately store their genomic data and control access to it. Shared data will be protected through zero-trust, encryption-based secure computing. Data owners will remain anonymous, while data buyers will be required to be fully transparent about their identity. The Nebula blockchain will immutably store all data transaction records. Addressing data privacy concerns will likewise accelerate growth of genomic data.

DATA ACQUISITION - The Nebula network will aggregate genomic data from individuals and genomic databanks and thereby address the problem of genomic data fragmentation. Direct communication with data owners and a smart survey tool will enable data buyers to collect high quality trait information. Utilization of standardized data formats will facilitate data curation. Smart contracts will automate and thereby accelerate data purchases.

GENOMIC BIG DATA - Genomic big data is projected to outgrow video and text data within the next few years. Through decentralized data storage, flexible utilization of available computing power and efficient file transfers enabled by space-efficient data encoding, the Nebula network will absorb the forthcoming data explosion.

活动

Nebula Genomics 球队

验证 0%

注意。未经证实的成员实际上可能不是团队成员

George Church
Co-founder
未验证
Dennis Grishin
Co-founder
未验证
Kamal Obbad
Co-founder
未验证
Armon Rahim
Growth Lead
未验证
Kevin Quinn
Engineer
未验证

顾问

验证 0%

注意。未经证实的成员实际上可能不是团队成员

Mirza Cifric
Advisor
未验证
Preston Estep
Advisor
未验证
Yining Zhao
Advisor
未验证
Drew Volpe
Advisor
未验证
Joe Urgo
Advisor
未验证
D. A. Wallach
Advisor
未验证
1.88
negative
5.0 4
ICO 轮廓 视力 活动 潜在 产品 球队

%name%Reviews

ICO Pantera
A

Advantages.
1. A very competent gene sequencing company called `veritas` is the parent company.
2. It provides genetic sequencing services rather than simple genetic testing services. It is recognized that it is promising market, and it can be said that there are almost no rivals on ICO market.
3. Team is strong and institutional investors who are solid. Advisors, especially George Church, are prominent.
A complementary point
1. There are strong market competitors including 23andme.
2. There are not many developers yet, and they are showing weakness in marketing. Active marketing is especially important in the coin market.
3. No code has been published yet, and no tokensale has been published.

阅读更多
Crypto Sherlock
6.8
阅读更多
  • 由于信息更新可能存在时间差异,因此应通过其官方网站或其他沟通渠道验证有关每个ICO项目的准确信息。
  • 这些信息不是投资ICO资金的建议或建议。请自行彻底调查相关信息并决定ICO的参与情况。
  • 如果您认为有任何问题需要纠正,或者您想提交自己的ICO项目,请给我们发送电子邮件。
请阅读免责声明和风险警告。 显示免责声明和风险警告。
Planning an ICO? We can help with a wide range of support for all stages of your ICO